Who May Benefit from This Treatment Patients with MASLD, MASH, obesity with confirmed hepatic steatosis, or type 2 diabetes with liver fat accumulation represent the most likely future candidates, subject to regulatory approval and individual clinical assessment
more severe reactions are less common but require evaluation
A number of recent studies dealing with the changes and benefits in gonadal dysfunction due to BS in obese men, are in agreement with BS-induced improvements in testosterone, SHBG and LH levels (129, 223, 224)
[5] [6] Some agents in this class (including liraglutide, semaglutide and dulaglutide) have demonstrated cardiovascular benefits in clinical trials, though specific benefits vary by individual medication
Further supporting these findings, a 2024 study by Kuryata and Frolova investigated the efficacy of 2 grams per day of L-carnitine in post-COVID patients dealing with long-term systemic complications
Even with this technology, only about 0.4-1% of the oral dose actually gets into your bloodstream